| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Revenue | $11.5M | -1.5% |
| Cost of Revenue | $3.8M | +93.0% |
| R&D Expense | $25.0M | +50.9% |
| SG&A Expense | $18.6M | +14.2% |
| Operating Income | -$45.9M | -48.9% |
| Interest Expense | $67K | -71.0% |
| Pre-tax Income | -$54.0M | -37.6% |
| Income Tax | $0 | — |
| Net Income | -$53.6M | -39.2% |
| EPS (Basic) | -$22.97 | +82.4% |
| EPS (Diluted) | -$22.97 | +82.4% |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Cash & Equivalents | $968K | -87.9% |
| Accounts Receivable | $1.5M | -0.4% |
| Inventory | $8.6M | -16.9% |
| Current Assets | $20.3M | -36.8% |
| Total Assets | $38.3M | -28.3% |
| Current Liabilities | $40.7M | +106.3% |
| Total Liabilities | $57.0M | +28.3% |
| Stockholders' Equity |
| Line Item | 2025-12-31 | Y/Y |
|---|---|---|
| Operating Cash Flow | -$23.7M | +19.4% |
| Capital Expenditures | $16K | +0.0% |
| Investing Cash Flow | -$41K | +82.3% |
| Financing Cash Flow | $23.7M | -24.1% |
| Free Cash Flow | -$23.7M | +19.4% |
| -$18.7M |
| -387.8% |